Showing 3731-3740 of 4590 results for "".
Antioxidants and Skin Cancer Risk: A Look at Vitamins A and B
https://practicaldermatology.com/topics/skin-cancer-photoprotection/antioxidants-and-skin-cancer-risk-a-look-at-vitamins-a-and-b/23106/There is some evidence to suggest that higher intake of these antioxidants may reduce skin cancer risks.Treatment of Psychodermatological Conditions Using N-acetylcysteine
https://practicaldermatology.com/columns/physician-spotlight/treatment-of-psychodermatological-conditions-using-n-acetylcysteine/23998/The low risk, high reward of NAC suggests its great promise in a supplementary role for treatment of trichotillomania and excoriation disorder.Vitiligo: Oral and Topical JAKs Show Promise
https://practicaldermatology.com/topics/pigmentary-disorders/vitiligo-oral-and-topical-jaks-show-promise/23316/Early studies offer some hope for emerging therapies for repigmentation.Affirming the Benefits of Full Body Skin Exams… And Overcoming Obstacles
https://practicaldermatology.com/topics/general-topics/PD0909_08-php/22772/Dermatologist-initiated full body skin exams identify skin cancers when they are most treatable. So why are some patients still not receiving exams?Update on TB Screening Prior To and During Biologic Treatment
https://practicaldermatology.com/columns/clinical-focus-1/update-on-tb-screening-prior-to-and-during-biologic-treatment/23220/Is annual screening in all patients really neccesary?Comorbidities in Vitiligo
https://practicaldermatology.com/issues/august-2025/comorbidities-in-vitiligo/36702/Vitiligo is a chronic, acquired pigmentary disorder characterized by the progressive loss of function or destruction of melanocytes in the skin, hair follicles, and mucous membranes. In this piece, Dr. Brad Glick and colleagues explore comorbidities in vitiligo.Cutaneous Superficial Leiomyosarcoma: A Treatment Conundrum
https://practicaldermatology.com/topics/general-topics/cutaneous-superficial-leiomyosarcoma-a-treatment-conundrum/21504/Select presentations given by dermatology residents at Cosmetic SurgeryExtended Half-Life and Long-Acting Biologics for the Treatment of Psoriasis
https://practicaldermatology.com/topics/psoriasis/extended-half-life-and-long-acting-biologics-for-the-treatment-of-psoriasis/60876/Explore the biologic rationale, emerging clinical candidates, and key unanswered questions surrounding extended half-life therapies for psoriatic disease.Optimizing Absorption of Oral Isotretinoin
https://practicaldermatology.com/columns/clinical-focus-1/optimizing-absorption-of-oral-isotretinoin/23066/An update on lidose-isotretinoin and the ability to enhance absorption in the absence of high-fat meals.Next Generation Environmental Protection: Antioxidants and Chelators
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/next-generation-environmental-protection-antioxidants-and-chelators/23802/As understanding of the pathogenesis of skin aging and carcinogenesis evolves, so do topical protective strategies.